VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
125 hedge funds and large institutions have $912M invested in Verve Therapeutics in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 34 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.67% more ownership
Funds ownership: 101.68% → 102.34% (+0.67%)
25% less capital invested
Capital invested by funds: $1.21B → $912M (-$300M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
125
Holding in Top 10
2
Calls
$1.98M
Puts
$485K
Top Buyers
| 1 | +$5.6M | |
| 2 | +$5.33M | |
| 3 | +$5.17M | |
| 4 |
Citigroup
New York
|
+$4.73M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$4.68M |
Top Sellers
| 1 | -$16.2M | |
| 2 | -$13.4M | |
| 3 | -$5.8M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$3.08M |
| 5 |
CC
Casdin Capital
New York
|
-$2.45M |